CoChat

Systemically Administered Bone Morphogenetic Protein-6 Restores Bone in Aged Ovariectomized Rats by Increasing Bone Formation and Suppressing Bone Resorption

Open access
Simic, Petra, Culej, Jasminka Buljan, Orlic, Iva, Grgurevic, Lovorka, Draca, Natasa, Spaventi, Radan, Vukicevic, Slobodan · 2006 · Journal of Biological Chemistry
Cited by 108

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Although recombinant human bone morphogenetic proteins (BMPs) are used locally for treating bone defects in humans, their systemic effect on bone augmentation has not been explored. We have previously demonstrated that demineralized bone (DB) from ovariectomized (OVX) rats cannot induce bone formation when implanted ectopically at the subcutaneous site. Here we showed in vitro that 17β-estradiol (E2) specifically induced expression of Bmp6 mRNA in MC3T3-E1 preosteoblastic cells and that bone extracts from OVX rats lack BMPs. Next we demonstrated that 125I-BMP-6 administered systemically accumulated in the skeleton and also restored the osteoinductive capacity of ectopically implanted DB from OVX rats. BMP-6 applied systemically to aged OVX rats significantly increased bone volume and mechanical characteristics of both the trabecular and cortical bone, the osteoblast surface, serum osteocalcin and osteoprotegerin levels, and decreased the osteoclast surface, serum C-telopeptide, and interleukin-6. E2 was significantly less effective, and was not synergistic with BMP-6. Animals that discontinued BMP-6 therapy maintained bone mineral density gains for another 12 weeks. BMP-6 increased in vivo the bone expression of Acvr-1, Bmpr1b, Smad5, alkaline phosphatase, and collagen type I and decreased expression of Bmp3 and BMP antagonists, chordin and cerberus. These results show, for the first time, that systemically administered BMP-6 restores the bone inductive capacity, microarchitecture, and quality of the skeleton in osteoporotic rats. Although recombinant human bone morphogenetic proteins (BMPs) are used locally for treating bone defects in humans, their systemic effect on bone augmentation has not been explored. We have previously demonstrated that demineralized bone (DB) from ovariectomized (OVX) rats cannot induce bone formation when implanted ectopically at the subcutaneous site. Here we showed in vitro that 17β-estradiol (E2) specifically induced expression of Bmp6 mRNA in MC3T3-E1 preosteoblastic cells and that bone extracts from OVX rats lack BMPs. Next we demonstrated that 125I-BMP-6 administered systemically accumulated in the skeleton and also restored the osteoinductive capacity of ectopically implanted DB from OVX rats. BMP-6 applied systemically to aged OVX rats significantly increased bone volume and mechanical characteristics of both the trabecular and cortical bone, the osteoblast surface, serum osteocalcin and osteoprotegerin levels, and decreased the osteoclast surface, serum C-telopeptide, and interleukin-6. E2 was significantly less effective, and was not synergistic with BMP-6. Animals that discontinued BMP-6 therapy maintained bone mineral density gains for another 12 weeks. BMP-6 increased in vivo the bone expression of Acvr-1, Bmpr1b, Smad5, alkaline phosphatase, and collagen type I and decreased expression of Bmp3 and BMP antagonists, chordin and cerberus. These results show, for the first time, that systemically administered BMP-6 restores the bone inductive capacity, microarchitecture, and quality of the skeleton in osteoporotic rats. Bone loss during aging and after menopause in women is known to result from an imbalance between bone formation and resorption leading to altered bone microarchitecture and excess bone fragility. Inferior bone strength and increased bone fracture rate of bone in patients with osteoporosis might be associated with decreased osteoinductive and thus self-regenerative bone capacity eventually due to the lower content of growth and differentiation factors including bone morphogenetic proteins in the bone extracellular matrix (1Cesnjaj M. Stavljenic A. Vukicevic S. Acta Orthop. Scand. 1991; 62: 471-475PubMed Google Scholar, 2Reddi A.H. Nat. Biotechnol. 1998; 16: 247-252Crossref PubMed Scopus (699) Google Scholar, 3Martinovic S. Simic P. Borovecki F. Vukicevic S. Vukicevic S. Sampath K. Bone Morphogenetic Proteins, Regeneration of Bone and Beyond. Birkhäuser Verlag, Basel2004: 45-72Crossref Google Scholar, 4Abe E. Yamamoto M. Taguchi Y. Lecka-Czernik B. O'Brien C. Economides A.N. Stahl N. Jilka R.L. Manolagas S.C. J. Bone Miner. Res. 2000; 15: 663-673Crossref PubMed Scopus (274) Google Scholar). Demineralized bone matrix (DBM) 2The abbreviations used are: DBM, demineralized bone matrix; OVX, ovariectomized;BMD,bonemineraldensity;CT,computerizedtomography;N,newton; ELISA, enzyme-linked immunosorbent assay; OPG, osteoprotegerin; IL, interleukin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ANOVA, analysis of variance; DTT, dithiothreitol; PTH, parathyroid hormone.2The abbreviations used are: DBM, demineralized bone matrix; OVX, ovariectomized;BMD,bonemineraldensity;CT,computerizedtomography;N,newton; ELISA, enzyme-linked immunosorbent assay; OPG, osteoprotegerin; IL, interleukin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ANOVA, analysis of variance; DTT, dithiothreitol; PTH, parathyroid hormone. induces de novo bone formation when implanted into the r

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m513276200

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

Metadata

Authors
Simic, P., Culej, J. B., Orlic, I., Grgurevic, L., Draca, N., Spaventi, R., & Vukicevic, S.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2006-09
Volume
281
Issue
35
Pages
25509-25521
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2104711663
Cited by
108
References
4
FWCI
3.07
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.